Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen and the aging brain.

I Silva1, G Mor, F Naftolin

  • 1Department of Obstetrics and Gynecology, Yale University School of Medicine, 333 Cedar St., FMB 335, PO Box 208063, New Haven, CT 06520-8063, USA.

Maturitas
|April 20, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lessons from KEEPS: the Kronos Early Estrogen Prevention Study.

Climacteric : the journal of the International Menopause Society·2020
Same author

Biopsy-induced inflammatory conditions improve endometrial receptivity: the mechanism of action.

Reproduction (Cambridge, England)·2014
Same author

p53 protein aggregation promotes platinum resistance in ovarian cancer.

Oncogene·2014
Same author

Bioinformatic analysis of benzo-α-pyrene-induced damage to the human placental insulin-like growth factor-1 gene.

Reproductive sciences (Thousand Oaks, Calif.)·2013
Same author

The PBRN initiative: transforming new technologies to improve patient care.

Journal of dental research·2012
Same author

Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potential.

Oncogene·2012
Same journal

Prevalence of, and factors associated with, urogenital pelvic floor disorders among women from a refugee-background: A cross-sectional study.

Maturitas·2026
Same journal

Association of menopausal type and hormone therapy with headache in a large Taiwanese cohort.

Maturitas·2026
Same journal

Depressive symptoms and risk of incident hip fracture in older adults: A harmonized multinational cohort study.

Maturitas·2026
Same journal

Depressive symptom trajectories around incident hip fracture in older adults: an event-centered matched analysis from the Health and Retirement Study.

Maturitas·2026
Same journal

Gut, vaginal, and urinary microbiome alterations in women with genitourinary syndrome of menopause: A systematic review.

Maturitas·2026
Same journal

Repurposing metformin: is it the new holy grail for longevity?

Maturitas·2026
See all related articles

Estrogen plays a key role in maintaining the aging brain by regulating the immune-brain barrier and microglial activation. Lower estrogen levels during menopause can lead to brain inflammation and neurodegenerative diseases like Alzheimer's.

Area of Science:

  • Neuroscience
  • Immunology
  • Endocrinology

Background:

  • Estrogen is implicated in brain function and maintenance, particularly in aging.
  • Estrogen influences the immune-brain barrier, a critical interface for brain homeostasis.

Purpose of the Study:

  • To hypothesize the role of estrogen in brain homeostasis through microglial regulation.
  • To explore the impact of diminished estrogen on the immune-brain barrier and brain pathology.

Main Methods:

  • Review of existing evidence on estrogen's role in brain function.
  • Analysis of data linking estrogen to immune-brain barrier regulation.
  • Hypothetical model development based on complementary data.

Main Results:

Related Experiment Videos

  • Estrogen regulates microglial activation, maintaining the brain's immune-privileged status.
  • Menopause-associated estrogen decline compromises the immune-brain barrier.
  • This compromise can foster brain inflammation and contribute to neurodegenerative diseases.

Conclusions:

  • Estrogen is crucial for maintaining brain homeostasis and protecting against inflammation.
  • Declining estrogen levels represent a significant risk factor for age-related brain pathologies, including Alzheimer's disease.
  • Targeting estrogen pathways may offer therapeutic strategies for neuroprotection.